相关实验视频

Updated: Jul 6, 2025

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

慢性缺氧通过自抑制稳定了3βHSD1

Liang Qin¹, Michael Berk², Yoon-Mi Chung³

¹Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.

|January 5, 2024

概括

缺氧通过抑制自,促进瘤生长来稳定前列腺癌的3βHSD1蛋白. 抑制胰岛素脱乙酶 (HDAC) 可能为缺氧瘤提供治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生化学

背景情况:

前列腺癌的进展依赖于雄激素受体信号传递,通常是向雄激素剥夺疗法.
耐药性发展为抵抗割的前列腺癌 (CRPC),由瘤合成的雄激素驱动.
3β-Hydroxysteroid脱酶/Δ5-->4异构酶1 (3βHSD1) 对于雄激素合成至关重要,但其蛋白质水平调节,特别是在缺氧的情况下,尚不清楚.

研究的目的:

通过缺氧来研究3βHSD1蛋白水平的调节机制.
了解自和基因素乙化在缺氧诱导的3βHSD1调节中的作用.
探索CRPC的潜在治疗点.

主要方法:

在体外实验中评估3βHSD1蛋白在低氧条件下的稳定性.
分析自活动及其与3βHSD1水平的关系.
调查基因素乙化和与自相关的 (ATG) 基因表达.
评估组织基因脱乙酶 (HDAC) 抑制效应.

主要成果:

发现缺氧通过抑制体外自来稳定3βHSD1蛋白.
自抑制与3βHSD1依赖性瘤进展的增加有关.
缺氧抑制ATG基因转录通过降低素乙化.
在低氧条件下,HDAC抑制恢复了ATG基因转录.

结论:

缺氧通过抑制自,稳定3βHSD1蛋白,从而促进CRPC的进展.
抑制HDAC是一种潜在的治疗策略,可以抵消前列腺癌中低氧驱动的雄激素合成.

关键词:

3βHSD1 的情况.CP: 癌症癌症癌症科普:分子生物学分子生物学雄激素合成与雄激素合成自自是自的过程.酵素酶是一种酶.细菌线的生殖线缺氧缺氧是指缺氧的情况.代谢过程中的代谢.前列腺癌是前列腺癌.蛋白质蛋白质是蛋白质蛋白质的组成部分.类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型:

更多相关视频

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

Induction and Testing of Hypoxia in Cell Culture

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Hypoxia

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...